Silexion's New Drug SIL204 Shows Promise Against Pancreatic Cancer Spread!

Silexion's new drug, SIL204, successfully reached & reduced metastatic pancreatic cancer in studies. It targets deadly tumor spread to liver, lung, and peritoneum. Human trials expected in H1 2026.